Onkure Therapeutics, Inc. · NASDAQ:OKUR
ACORN BIOVENTURES, L.P. reported a 13.30% stake in Onkure Therapeutics, Inc. (Schedule 13D)
Event May 15, 2025 · Filed May 22, 2025
ACORN BIOVENTURES, L.P. reported a 13.30% stake in Onkure Therapeutics, Inc., 1,709,944 shares, with active intent on May 15, 2025. Filed May 22, 2025 (Schedule 13D).
- Stake
- 13.30%
- Shares
- 1,709,944
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 13.30% | 1,709,944 |
| ACORN CAPITAL ADVISORS GP, LLC | 13.30% | 1,709,944 |
| Anders Hove | 22.10% | 2,839,674 |
| ACORN BIOVENTURES 2, L.P. | 8.80% | 1,129,730 |
| Acorn Capital Advisors GP 2, LLC | 8.80% | 1,129,730 |
Source
Related
- Onkure Therapeutics, Inc.
- Anders Hove
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Anders Hove · Apr 1, 2026
- Schedule 13D/A · Anders Hove · May 30, 2025
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026